Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy
Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy
复制标题
DOI：
10.1016/j.coph.2020.11.004
复制
发表时间：
2021-02-01
影响因子：
4
通讯作者：
Barnes, Peter J.
中科院分区：
文献类型：
--
作者：
Barnes, Peter J.
Increasing evidence suggests that there is acceleration of normal lung ageing in chronic obstructive pulmonary disease (COPD), with the accumulation of senescent cells in the lung, which release an array of inflammatory proteins, which drive further senescence and disease progression. This suggests that drugs that target cellular senescence (senotherapies) may treat the underlying disease process in COPD and reduce disease progression and mortality. Several existing or future drugs may inhibit the development of cellular senescence, which is driven by chronic oxidative stress (senostatics), whereas other drugs selectively remove senescent cells (senolytics). Clinical studies of senotherapies have commenced in several age-related diseases, and these approaches appear to be safe and feasible, although no clinical studies in COPD patients have yet been reported.
